Tirzepatide was linked to improved weight loss outcomes in patients with PCOS, especially those who used a digital weight ...

CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

More than 90% of women with polycystic ovary syndrome achieved at least 10% total weight loss after 10 months of tirzepatide ...

Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's ...

One big reason Lilly stock has potential is Medicare, the government-run health insurance program for seniors that is the single largest healthcare payer in the U.S.